Xiaoyu Cheng
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
-
- Cancer-related molecular mechanisms research
Papers in
- Nephrology 16
- Gout, Hyperuricemia, Uric Acid 16
-
- Inflammasome and immune disorders 2
- Co-authors
- Wenfeng Zhang (1 shared paper)Xi Rao (1 shared paper)Liang Wang (1 shared paper)Ming Li (1 shared paper)Xiaopeng Li (1 shared paper)Changgui Li (14 shared papers)Lidan Ma (9 shared papers)Ying Xin (6 shared papers)
- Journals
- Arthritis Research & Therapy (2 papers)Arthritis Care & Research (2 papers)Advanced Healthcare Materials (1 paper)Lara D. Veeken (1 paper)Journal of Nanobiotechnology (1 paper)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Xiaoyu Cheng
45 papers receiving 689 citations
Peers
Comparison fields: 5 of 97
- Nephrology 225
- Cancer Research 101
- Molecular Biology 259
- Pharmacology 28
- Rehabilitation 19
Countries citing papers authored by Xiaoyu Cheng
This map shows the geographic impact of Xiaoyu Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyu Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyu Cheng more than expected).
Fields of papers citing papers by Xiaoyu Cheng
This network shows the impact of papers produced by Xiaoyu Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyu Cheng. The network helps show where Xiaoyu Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoyu Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 132 | |
| 2 | 2017 | 114 | |
| 3 | 2016 | 52 | |
| 4 | 2024 | 42 | |
| 5 | 2024 | 30 | |
| 6 | 2019 | 30 | |
| 7 | 2019 | 29 | |
| 8 | 2017 | 27 | |
| 9 | 2020 | 23 | |
| 10 | 2023 | 21 | |
| 11 | 2023 | 21 | |
| 12 | 2022 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2018 | 12 | |
| 16 | 2016 | 11 | |
| 17 | 2019 | 10 | |
| 18 | 2009 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2019 | 7 |
About Xiaoyu Cheng
Xiaoyu Cheng is a scholar working on Nephrology, Molecular Biology, Surgery, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 51 papers that have together received 695 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (16 papers), Ocular Surface and Contact Lens (3 papers), Case Reports on Hematomas (3 papers), Corneal Surgery and Treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Sleep and Wakefulness Research (2 papers), Restless Legs Syndrome Research (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Nephrology (225 citations), Cancer Research (101 citations), Molecular Biology (259 citations), Pharmacology (28 citations) and Rehabilitation (19 citations). Xiaoyu Cheng has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Wenfeng Zhang, Xi Rao, Liang Wang, Ming Li, Xiaopeng Li, Changgui Li, Lidan Ma, Ying Xin, Ruixia Sun and Xue‐Yin Pan. Their work appears in journals such as Arthritis Research & Therapy, Arthritis Care & Research, Advanced Healthcare Materials, Lara D. Veeken and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.